294 related articles for article (PubMed ID: 34076804)
21. How can we help you? A qualitative study of the provision of care to culturally and linguistically diverse clients in community pharmacy.
Filmer TR; Ray RA; Glass BD
Int J Pharm Pract; 2023 Dec; 31(6):601-607. PubMed ID: 37706657
[TBL] [Abstract][Full Text] [Related]
22. Pharmacy practitioners' lived experiences of culture in multicultural Australia: From perceptions to skilled practice.
Fejzic J; Barker M
PLoS One; 2019; 14(6):e0217673. PubMed ID: 31216322
[TBL] [Abstract][Full Text] [Related]
23. Pharmacists views on participating in New Zealand's community pharmacy anticoagulation management service: a mixed-methods study.
Beyene K; Chan AHY; Barton E; Yan S; Singh S; Basani A; Voong J; Harrison J
Int J Clin Pharm; 2021 Feb; 43(1):251-262. PubMed ID: 32920685
[TBL] [Abstract][Full Text] [Related]
24. Pharmacist's time spent: Space for Pharmacy-based Interventions and Consultation TimE (SPICE)-an observational time and motion study.
Karia A; Norman R; Robinson S; Lehnbom E; Laba TL; Durakovic I; Balane C; Joshi R; Webster R
BMJ Open; 2022 Mar; 12(3):e055597. PubMed ID: 35236731
[TBL] [Abstract][Full Text] [Related]
25. Sleep health management in community pharmacy: Where are we and where should we be heading?
Basheti MM; Gordon C; Bawa Z; Grunstein R; Saini B
Res Social Adm Pharm; 2021 Nov; 17(11):1945-1956. PubMed ID: 33602626
[TBL] [Abstract][Full Text] [Related]
26. Considerations of Australian community pharmacists in the provision and implementation of cognitive pharmacy services: a qualitative study.
Yong FR; Hor SY; Bajorek BV
BMC Health Serv Res; 2021 Sep; 21(1):906. PubMed ID: 34479542
[TBL] [Abstract][Full Text] [Related]
27. Pharmacists' experience of a diabetes risk-assessment service and analytical quality control in community pharmacies - A focus-group study.
Risøy AJ; Skeide Kjome RL; Svensberg K; Råheim M; Sølvik UØ
Res Social Adm Pharm; 2021 Jul; 17(7):1259-1266. PubMed ID: 34155978
[TBL] [Abstract][Full Text] [Related]
28. Australian community pharmacists' awareness and practice in supporting secondary prevention of cardiovascular disease.
Puspitasari HP; Aslani P; Krass I
Int J Clin Pharm; 2013 Dec; 35(6):1218-28. PubMed ID: 24057435
[TBL] [Abstract][Full Text] [Related]
29. Community pharmacists' perspectives about the sustainability of professional pharmacy services: A qualitative study.
Crespo-Gonzalez C; Benrimoj SI; Scerri M; Garcia-Cardenas V
J Am Pharm Assoc (2003); 2021; 61(2):181-190. PubMed ID: 33262025
[TBL] [Abstract][Full Text] [Related]
30. Successful implementation and provision of enhanced and extended pharmacy services.
Hattingh L; Sim TF; Sunderland B; Czarniak P
Res Social Adm Pharm; 2020 Apr; 16(4):464-474. PubMed ID: 31272922
[TBL] [Abstract][Full Text] [Related]
31. Perspectives on an amended law addressing pharmacists' availability in community pharmacies.
Qadeer G; Amin MEK
J Eval Clin Pract; 2021 Feb; 27(1):151-157. PubMed ID: 32319720
[TBL] [Abstract][Full Text] [Related]
32. Australian mental health consumers and carers expect more health management information from community pharmacy.
Fejzic J; Knox K; Hattingh HL; Mey A; McConnell D; Wheeler AJ
Int J Pharm Pract; 2017 Dec; 25(6):454-462. PubMed ID: 28303618
[TBL] [Abstract][Full Text] [Related]
33. Perinatal depression screening in community pharmacy: Exploring pharmacists' roles, training and resource needs using content analysis.
Strowel C; Raynes-Greenow C; Pham L; Carter S; Birkness K; Moles RJ; O'Reilly CL; Chen TF; Raduescu C; Murphy A; Gardner D; El-Den S
Int J Clin Pharm; 2023 Oct; 45(5):1212-1222. PubMed ID: 37792255
[TBL] [Abstract][Full Text] [Related]
34. Key stakeholder perspectives on the barriers and solutions to pharmacy practice towards complementary medicines: an Australian experience.
Ung COL; Harnett J; Hu H
BMC Complement Altern Med; 2017 Aug; 17(1):394. PubMed ID: 28793918
[TBL] [Abstract][Full Text] [Related]
35. 'Creating a culturally competent pharmacy profession': A qualitative exploration of pharmacy staff perspectives of cultural competence and its training in community pharmacy settings.
McCann J; Lau WM; Husband A; Todd A; Sile L; Doll AK; Varia S; Robinson-Barella A
Health Expect; 2023 Oct; 26(5):1941-1953. PubMed ID: 37357812
[TBL] [Abstract][Full Text] [Related]
36. What is needed in culturally competent healthcare systems? A qualitative exploration of culturally diverse patients and professional interpreters in an Australian healthcare setting.
White J; Plompen T; Tao L; Micallef E; Haines T
BMC Public Health; 2019 Aug; 19(1):1096. PubMed ID: 31409317
[TBL] [Abstract][Full Text] [Related]
37. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS.
Blake KB; Madhavan SS
Ann Pharmacother; 2010 Mar; 44(3):424-31. PubMed ID: 20179254
[TBL] [Abstract][Full Text] [Related]
38. Knee osteoarthritis and the knowledgeable, trustworthy pharmacist: Patient and pharmacist perceptions of community pharmacy-based education and support.
Darlow B; Brown M; Hudson B; Frew G; Clark J; Vincent L; Grainger R; Marra C; McKinlay E; Abbott JH; Briggs AM
Musculoskeletal Care; 2023 Mar; 21(1):3-15. PubMed ID: 35615979
[TBL] [Abstract][Full Text] [Related]
39. Survey of Georgia community pharmacists' needs to engage in advanced community pharmacy services.
Hazelett KG; Keedy C; Fraley AD; Bazel K; Crosby J; Johnson BR
J Am Pharm Assoc (2003); 2024; 64(2):517-523.e2. PubMed ID: 38097176
[TBL] [Abstract][Full Text] [Related]
40. Pharmacists experience of and perspectives about recruiting patients into a community pharmacy asthma service trial.
Bertilsson E; Serhal S; Emmerton L; Bosnic-Anticevich S; Krass I; Bereznicki B; Bereznicki L; Armour C; Saini B
Res Social Adm Pharm; 2021 Mar; 17(3):595-605. PubMed ID: 32448767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
